We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Santhera Receives FDA Fast Track Designation for Raxone®/Catena®

News   Apr 10, 2015

 
Santhera Receives FDA Fast Track Designation for Raxone®/Catena®
 
 
 

RELATED ARTICLES

Drug Reduces Menstrual Bleeding for Women with Gynecologic Tumors

News

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

READ MORE


Gold Nanoparticles Act as Tumor-seeking Missiles

News

A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth).

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE